Thirty-five patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy underwent serial electrocardiographic(ECG) testing and were evaluated for evidence of ECG progression. Over a median of 43 months, 8...Thirty-five patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy underwent serial electrocardiographic(ECG) testing and were evaluated for evidence of ECG progression. Over a median of 43 months, 89%of the patients had evidence of progression, with S-wave prolongation being the most prevalent marker of ECG progression.展开更多
文摘Thirty-five patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy underwent serial electrocardiographic(ECG) testing and were evaluated for evidence of ECG progression. Over a median of 43 months, 89%of the patients had evidence of progression, with S-wave prolongation being the most prevalent marker of ECG progression.
